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Muscle loss is a severe complication of many medical conditions such as cancer,
cardiac failure, muscular dystrophies, and nerve damage. The contribution of myofibrillar
protein synthesis (MPS) to the loss of muscle mass after nerve damage is not
clear. Using deuterium oxide (D2O) labeling, we demonstrate that MPS is significantly
increased in rat m. tibialis anterior (TA) compared to control (3.23 ± 0.72 [damaged] to
2.09 ± 0.26%∗day−1 [control]) after 4 weeks of nerve constriction injury. This is the case
despite substantial loss of mass of the TA (350 ± 96 mg [damaged] to 946 ± 361 mg
[control]). We also show that expression of regulatory proteins involved with MPS
(p70s6k1: 2.4 ± 0.3 AU [damaged] to 1.8 ± 0.2 AU [control]) and muscle protein
breakdown (MPB) (MAFbx: 5.3 ± 1.2 AU [damaged] to 1.4 ± 0.4 AU [control]) are
increased in nerve damaged muscle. Furthermore, the expression of p70s6k1 correlates
with MPS rates (r2 = 0.57). In conclusion, this study shows that severe muscle wasting
following nerve damage is accompanied by increased as opposed to decreased MPS.
Keywords: skeletal muscle, atrophy, muscle loss, myofibrillar, protein synthesis, nerve damage, stable isotope,
deuterium oxide
INTRODUCTION
Skeletal muscle is the biggest organ of the human body, comprising at least 40% of its mass
and containing 50–75% of all body proteins (Frontera and Ochala, 2015). It is pivotal to health
and locomotion, and the lack of muscle mass and strength is associated with severely reduced
independence, quality of life, and life expectancy (Metter et al., 2002; Wannamethee et al., 2007).
Many clinical conditions are accompanied by muscle loss, such as cancer, COPD, or heart failure
(Rosenberg, 1997; Al-Majid and McCarthy, 2001; Marquis et al., 2002; Thomas, 2007). Currently,
no drug treatment for muscle wasting is available, with exercise and ample protein intake being the
only bona fide intervention to slow muscle loss (Sepulveda et al., 2015; Garber, 2016). However,
there are situations of muscle loss where physical activity is not an option. Such as in patients
with fractures, critically ill patients or nerve damage. Peripheral nerve damage is a frequently
occurring clinical condition that can be caused by disease or trauma (Dyck, 2005). A common
model to study peripheral nerve damage is chronic constriction injury to the nerve (Bennett and
Xie, 1988). Chronic constriction injury to the nerve is accompanied by debilitating symptoms
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such as neuropathic pain, hampered motor function and skeletal
muscle atrophy (Bennett and Xie, 1988). Even though nerve
function may recover, this is often outlasted by the deteriorating
effects on muscle tissue. Although chronic nerve constriction is
well investigated in respect to its implications for pain in animals,
very little is known on the physiology of muscle wasting.
Muscle mass is determined by the balance between muscle
protein synthesis (MPS) and muscle protein breakdown (MPB).
Either side of the balance may be disturbed. Consequently,
most muscle atrophies are assumed to show a combination of
decreased MPS and increased MPB (McKinnell and Rudnicki,
2004). Yet, the individual contribution of decreased MPS may
differ between various types of atrophies. For example in
disuse atrophy in humans, blunted MPS rates seem to be the
predominant cause for a decline in muscle mass (Wall et al.,
2013a,b, 2016). Similarly, decreased MPS has been reported for
starvation, sarcopenia, cachexia, and other conditions of muscle
wasting, indicating a potential benefit of interventions which
increase MPS (Emery et al., 1984; Yarasheski et al., 1993; Hector
et al., 2018). In nerve damage induced atrophy, early work has
suggested varying effects of denervation on MPS. Depending
on the time point, decreased as well as transiently increased
MPS rates were found in very young rats after nerve transection
(Goldspink, 1976, 1978; Goldspink et al., 1983). How MPS rates
are affected by chronic nerve constriction in adult animals is
not known. Furthermore, previous studies using stable isotope
labeling with the flooding dose- or primed continuous infusion
technique were restricted to an MPS assessment period of a few
hours, reducing their ability to predict absolute changes in muscle
mass (Mitchell et al., 2014; Reid et al., 2014). The reemergence
of deuterium oxide (D2O) as a mean to study integrated MPS
in vivo over multiple days- or weeks, however, offers an attractive
solution for this problem (Busch et al., 2006; Wilkinson et al.,
2014; Damas et al., 2016).
Therefore we set out to investigate the effects of chronic nerve
constriction on MPS. We combined long term D2O-mediated
tracer experiments in adult rats with absolute changes in muscle
mass, immunohistochemical analysis and protein expression
data. We hypothesized that nerve constriction would cause a
decrease in MPS rates. However, we found that despite substantial
muscle loss, nerve damage induced atrophy is accompanied by
chronically elevated as opposed to reduced myofibrillar protein
synthesis (MPS) rates.
MATERIALS AND METHODS
Ethical Approval and Animal Experiments
The animal experiments were approved by the local authority
(Landesamt für Gesundheit und Soziales, Berlin, Germany)
under the reference G 0083/15 and performed at the animal care
unit of the Max Delbrück Center for Molecular Medicine (MDC,
Berlin).
Nerve-Damage Model
Ten male Sprague-Dawley rats [Crl:CD (SD), Charles River,
Sulzfeld, Germany] between 20–21 weeks of age were housed
in individual cages. The animals were fed a diet of 20 g chow
(ssniff Spezialdiäten GmbH, Soest, Germany) (Supplementary
Figure 1) equivalent to 79 kcal∗day−1 to slow down commonly
occurring weight gain. Nerve damage was induced via chronic
constriction injury to the sciatic nerve (Sommer, 2013). The rats
were anesthetized via isoflurane inhalation (∼2.5%) and treated
with an injection of 4–5 mg carprofen ∗kg−1 bodyweight to
reduce postsurgical pain. An incision was made along the femur,
and the vastus lateralis was disconnected from the biceps femoris
by blunt dissection. The sciatic nerve was exposed above the point
of trifurcation and constriction injury was induced by implanting
a cuff around the nerve. To further reduce postsurgical pain of
the animals, they received 100 mg ∗kg−1 metamizole. For the
last 2 weeks, the animals were electrostimulated twice a week
to maintain the nerve injury and impair recovery, as has been
described previously (Baptista et al., 2008; Gigo-Benato et al.,
2010). The animals were dissected 4 weeks post surgery, between
the age of 24 and 25 weeks. In a fasted state, the animals were
put under deep anesthesia via isoflurane inhalation (∼3.5%) and
the TA and extensor digitorum longus (EDL) were collected.
Muscles were quickly weighed and cut in half, with one part being
immediately snap frozen in liquid nitrogen and the other part
being embedded in gum tragacanth for histological analysis and
frozen in isopentane.
D2O Labeling Protocol
We used a labeling protocol suitable to detect deuterium (2H)
enrichments in alanine of the myofibrillar protein fraction of
skeletal muscle via GC-MS similar to what has been published
previously (Busch et al., 2006; Gasier et al., 2009). Briefly, 2 weeks
after surgery the animals received an intraperitoneal injection of
0.014 mL ∗g−1 bodyweight of D2O (99.8%+Atom D, Euriso-Top
GmbH Saarbrücken) and 0.9% NaCl. This injection primed the
animals and enriched their body water levels to approximately
2.5% D2O. To maintain the label concentration, the rats received
drinking water with 4% 2H2O enrichment.
Myofibrillar Protein Extraction
Myofibrillar protein isolation was performed as described
previously (Burd et al., 2012). Briefly, 80–120 mg muscle sample
of rat TA (n = 10) was weighed into an Eppendorf tube and
stored on ice. A standard buffer solution was added to each
sample at 10 µL ∗mg−1 and the muscle tissue was thoroughly
homogenized. Scissors were used to mince the tissue before
subsequent homogenization by plastic pestles. To fractionate a
pellet rich in myofibrillar- and other structural proteins, the
sample was spun at 700 g for 10 min at 4◦C. The remaining
pellet was washed twice with buffer and dH2O, the supernatant
was discarded and 1 mL 0.3 NaOH was added to the pellet
to further solubilize the myofibrillar proteins and isolate them
from collagen. The samples were heated at 50◦C for 30 min.
Subsequently the sample was spun at 10,000 g for 5 min at
4◦C and the supernatant containing the myofibrillar protein was
transferred into 4 mL screw-cap glass vials. One milliliter of 1M
PCA was added to each glass vial to denaturate the remaining
proteins. After centrifugation, the supernatant was removed and
the pellet washed twice with 500 µL 70% EtOH. After removal
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of the EtOH, 1.5 mL of 6M HCL was added to hydrolyze the
samples over night at 110◦C. The next day the samples were
put in a heating block (120◦C) and dried under a nitrogen
steam. To further purify the amino acids, the samples were
passed through Dowex exchange resin (AG 50W-X8 Resin, Bio-
Rad) prior to derivatization. After purification, the glass vials
were carefully vortexed and put under a nitrogen steam to dry
before derivatization. Samples containing the free amino acids
of the myofibrillar protein fraction were then converted to their
tert-butyldimethylsilyl (TBDMS) derivatives via the addition of
50 µL of N-tert-Butyldimethylsilyl-N-methyltrifluoroacetamide
(MTBSTFA) and 50µL of acetonitrile to the sample. Each sample
was then incubated for 1 h at 70◦C. The sample was then
transferred to 2 mL screw-cap chromacol vials (Thermo Fisher
Scientific, Schwerte, Germany) suitable for GC-MS injection.
Plasma Protein Extraction
To precipitate plasma protein, 40 µL perchloric acid (20%)
were added to 360 µL plasma sample. After vortexing, free
amino acids were separated from protein bound amino acids by
centrifugation (3500 rpm, 20 min, 4◦C). The pellet was collected
and washed three times with 1 mL perchloric acid (2%) before
being hydrolyzed over night as described above. After hydrolysis,
samples were purified and processed for GC-MS injection as
described above. Values of unlabeled samples were used as a
baseline control for 2H enrichment in plasma protein bound
alanine.
Free Alanine Enrichments in Plasma
Plasma samples were thawed on ice and dry 5-sulfosalicylic acid
was added to the sample to deproteinize it as described previously
(Trommelen et al., 2016). After vortexing, the sample was spun
at 1000 g for 15 min. The supernatant was collected and then
purified, processed and measured on the GC-MS as described in
the sections above.
GCMS Measurement and Stable Isotope
Enrichment Analysis
The alanine enrichment was determined by electron ionization
gas chromatography-mass spectrometry (GC-MS; Agilent 6890N
GC/5973N MSD) using selected ion monitoring of masses 232,
233, 234, 235, and 236 for their unlabeled and labeled H2-alanine.
We applied standard regression curves to assess linearity of the
mass spectrometer and to control for the loss of tracer.
Immunoblotting
Approximately 400 µm of sample was cut from the histology
block and homogenized in a standard lysing buffer using a pestle.
Protein concentrations in the samples were determined using a
bicinchoninic acid assay (BCA) kit (Thermo Fisher Scientific,
Schwerte, Germany). The required volume for 40 µg of protein
per sample was calculated, aliquoted and SDSPP (6×) and SDSPP
in H2O (1×) were added for a total volume of 15µL. Commercial
SDS gels (Invitrogen NuPAGE Bis-Tris Gel, Thermo Fisher
Scientific, Schwerte, Germany) and electrophoresis (130–200 V)
were used to separate the proteins in each sample. The semi-
dry blot technique was used for transfer (45 min at 18 V).
Membranes were blocked in TBS-T (4% milk powder) for 1 h
at room temperature. Membranes were then incubated with the
first antibody in TBS-T (4% milk powder) or BSA overnight
(Supplementary Figure 9). The next day, samples were washed
in TBS-T and the second antibody was added for 60 min at room
temperature. After washing, chemiluminescence (ECL) was used
for development of the bands. Expression levels of the protein
bands of interest were directly analyzed using Image Studio Lite
(LI-Cor, Lincoln, NE, United States). Protein loading and transfer
was controlled for with a ponceau s staining (Supplementary
Figure 2).
Histochemistry and
Immunofluorescence
Gomori trichrome and toluidine blue ATPase stainings were
performed according to an established protocol (Engel and
Cunningham, 1963; Ogilvie and Feeback, 1990). For the fiber type
distribution, as many fibers per slice were measured as clearly
distinguishable by the toluidine blue staining. For type 2 fibers
this was approximately 50 per slide, for the far less abundant type
1 fibers approximately 10.
For immunofluorescence staining, freshly cut cryosections
were left 1 h at RT to dry and then fixated in 3.7%
paraformaldehyde. Subsequently, sections were washed and
blocked in 3% BSA/PBS. Afterward sections were incubated
with anti-GLUT4 antibody (Supplementary Figure 9), CT-3,-
3/5; 1:1000 in PBS (1% BSA) for 1 h at room temperature. The
sections were incubated with biotin anti rabbit (1:200) in PBS and
Streptavidin-Cy3 (1:200). Nuclei were visualized with Hoechst
(1:1000 in PBS) before being mounted on slides using Aqua
Mount (Thermo Fisher Scientific, Schwerte, Germany).
Pictures were acquired using a Zeiss LSM 700 confocal
microscope (Zeiss, Jena, Germany) and the associated vendor
software Zen 2012. Mosaic pictures of the TA were created
with a Leica DFC 420 microscope (Leica Microsystems, Wetzlar,
Germany). Fiber number was analyzed by counting every single
fiber of the section.
Body Composition Analysis
Body composition was measured using the Minispec LF90 II time
domain NMR analyzer (6.5 mHz, Bruker Optics, United States).
Rats were placed into a restraint tube and inserted into the
instrument which measured fat mass, fat-free mass, and fluid
content of the animal.
Fractional Synthesis Rate Calculations
Myofibrillar protein synthesis rates were calculated using the
precursor-product method (Wall et al., 2013b).
FSR (%∗d−1) = (1MPEmyo/(1MPEplasma∗t))∗100
where FSR is the fractional synthesis rate of myofibrillar proteins,
1MPEmyo is the change in enrichment of 2H in muscle protein-
bound alanine,1MPEplasma is the change in enrichment of 2H in
alanine found in plasma and t is time.
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Statistics
Statistical tests were applied as appropriate depending on the
sample- and group number. Data are expressed as scatter dot plot
with the line indicating the mean, mean ± standard deviation
or floating bars (minimum to maximal value) with the line
indicating the mean. After testing for normality of the data,
Student’s t-test or ANOVA with Tukey’s post hoc test were applied
depending on the number of groups. p-Values below 0.05 were
deemed significant.
RESULTS
Nerve Damage Induces Substantial
Muscle Loss
We induced sciatic nerve damage in otherwise healthy, male SD
rats. We observed a fully developed muscle wasting phenotype
at 28 days post surgery (Figures 1A–D). Immediately after
surgery, the animals showed signs of decreased innervation
of the hind limb affected, as expected after peripheral nerve
injury (Gigo-Benato et al., 2010). The animals did not show
any symptoms of decreased alertness or daily activity. Sciatic
nerve innervated muscles lost significant mass: After 28 days TA
mass had decreased by 66%, from 946 to 350 mg (Figure 1B),
EDL by 50% from 264 to 132 mg (Figure 1C). In the m.
soleus (SOL), loss of mass was less pronounced. Muscle weight
decreased from 252 to 156 mg which approximates a 38% loss
in muscle mass (Figure 1D). Since the SOL is almost exclusively
composed of type 1 fibers (Gregory et al., 2001), this might hint
toward a predominant type 2 fiber atrophy in association with
disuse, rather than neurogenic atrophy. We followed this up via
histological analysis.
Fiber Atrophy and Deteriorated Body
Composition
Histological analysis at day 28 after initiation of nerve damage
revealed signs of necrotizing myopathy with regenerating fibers,
fibers with centrally located nuclei, necrotic, and atrophic fibers
(Figure 2A). The Feret’s diameter ranged from 43–51 µm in
healthy type 1 fibers, and from 30–37 µm in damaged type 1
fibers (Figure 2B). In type 2a fibers, Feret’s diameter ranged
from 43–53 µm in healthy muscle and 28–47 µm in damaged
muscle (Figure 2B). Type 2b fibers ranged from 52–63 µm
in healthy, and 29–43 µm in damaged muscle (Figure 2B).
Overall, nerve damage induced a decrease in fiber diameter
in all three fiber types (Figure 2B). In our study the type 2b
fibers were most affected, decreasing by 41% ( ± 13%) in Feret’s
diameter (Figure 2B). When type 2a and -b fibers were clustered,
the loss of fiber diameter was greater than in type 1 fibers
(Supplementary Figure 3). This confirms that the loss of muscle
mass is predominantly based on type 2 fiber atrophy and explains
why the SOL showed the least decline in muscle mass, being
composed almost exclusively of type 1 fibers (Gregory et al.,
2001). The total number of fibers in a complete cross section of
TA from control and nerve damaged muscle were counted. In
healthy muscle we found 13980± 999 compared to 13270± 652
fibers in damaged muscle (Figure 2C). These data indicate that
muscular atrophy was due to loss of mass in individual fibers
rather than reduction of total number of fibers, all consistent with
muscular atrophy rather than dystrophy.
We asked whether sciatic nerve-induced atrophy resulted in
overall changes in body composition. From day 0 to 28 days post
surgery, we detected a 3.7% (± 1.3%) decrease in lean body mass
from 75.4% (± 2.3%) to 71.7% (± 2.9%) (Figure 2D). The loss of
lean body mass percentage occurred despite a tendency toward an
increase in bodyweight (p = 0.61; Supplementary Figure 7). The
decrease in lean body mass was accompanied by a slight increase
in body fat percentage (Figure 2D).
Increased Myofibrillar Protein Synthesis
in Atrophic Muscle
Deuterium oxide was injected and then added to regular
water supply to analyze myofibrillar fractional synthetic rate
(Figure 3A). We confirmed our ability to reliably detect 2H
labeled alanine in a vast amount of different rat muscle samples,
obtained from several interventions which have utilized D2O
(Figure 3B). Myofibrillar fractional synthetic rate was increased
1.6-fold in the damaged compared to the control leg after
2 weeks of D2O treatment (3.23 ± 0.72 to 2.09 ± 0.26%∗day−1,
respectively) (Figure 4). Every single animal (n = 10) showed
increased muscle protein synthesis rates in the damaged
compared to the control leg (Supplementary Figure 4). To our
knowledge, this is the first study showing an integrated increase
in MPS during a prolonged period of loss of muscle mass.
Expression of Key Signaling Proteins
Regulating Muscle Size
Skeletal muscle proteolysis is partially regulated by the E3
ubiquitine proteasome pathway and its muscle specific ligases
MAFbx and MuRF1 (Bodine et al., 2001). To investigate how
key signaling proteins of the proteasome pathway are regulated
in our model, we investigated MAFbx and MuRF1 by Western
blot analysis. Expression of MAFbx was increased fourfold in
the damaged versus the control leg (5.3 ± 1.2 to 1.4 ± 0.4 AU,
respectively) (Figure 5A, upper panel). MuRF1 expression
followed a similar pattern (p < 0.0001) (Supplementary
Figure 5). Protein expression of p70s6k1 increased 1.4-fold in the
damaged leg (2.4± 0.3 to 1.8± 0.2 AU) (Figure 5A, lower panel).
Phosphorylated p70s6k1 could not be detected (Supplementary
Figure 6). We found a correlation between p70s6k1 expression
and myofibrillar fractional synthesis rates (r2 = 0.57) (Figure 6A).
The correlation for p70s6k1 and FSR is independent of the
intervention effect and still present if the analysis is restricted to
the control leg (r2 = 0.65) (Supplementary Figure 8).
DISCUSSION
The most prevalent assumption is that in most situations of
muscle loss, there is a decrease in protein synthesis as well an
increase in protein breakdown (McKinnell and Rudnicki, 2004).
In disuse atrophy and immobilization in humans, a decrease
in MPS appears to be the predominant mechanism causing
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FIGURE 1 | (A) Mosaic picture of rat tibialis anterior stained with GLUT4. (B) Nerve damage induces substantial muscle loss in m. tibialis anterior (TA) (n = 10),
(C) m. extensor digitorum longus (EDL) (n = 10), and (D) m. soleus (SOL) (n = 9). ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
muscle loss (Wall et al., 2013a; Phillips and McGlory, 2014).
A decrease in MPS has also been observed for diet induced
muscle atrophy in obese men, cancer cachexia, sepsis, and burned
patients (Emery et al., 1984; Sakurai et al., 1995; Lang et al., 2007;
Hector et al., 2018). In our study, we investigated chronic changes
in MPS in response to nerve damage induced muscle atrophy.
In stark contrast to the scenarios mentioned above, we found
that MPS rates are increased as opposed to decreased during
nerve damage induced muscle loss (Figure 4). Early studies
on MPS after nerve damage have found varying results. MPS
was reported to be transiently increased in vitro and in vivo
by Buse, Goldspink and others (Buse et al., 1965; Goldspink,
1976, 1978). Later work has shown a decrease in MPS in muscle
that has undergone compensatory growth with subsequent nerve
transection (Goldspink et al., 1983). However, the implications
of these studies differ profoundly from our findings. One reason
are the differences between the nerve damage models: while a lot
of work has been done on nerve transection, less is known for
chronic constriction injuries to the nerve, which was the model in
this study. In fact, no study thus far had investigated how muscle
protein turnover and MPS are affected by nerve constriction
injury. Furthermore, the studies finding an increase in tracer
incorporation into the EDL and SOL after nerve transection were
performed in particularly young rats (Goldspink, 1976, 1978).
Undergoing age related growth, these animals still increased
absolute mass of the denervated muscle over the course of
the experiment (Goldspink, 1976, 1978). The result was slowed
growth and relative atrophy of the affected muscles compared
to control animals rather than absolute atrophy. In the face of
a systemically anabolic environment, increased MPS rates may
be less surprising. We chose full grown, adult rats (21–22 weeks
old) and controlled their food intake to avoid excess bodyweight-
and associated muscle gains (Supplementary Figure 7). Over the
course of 4 weeks after the surgery our animals lost 66% of the
TA compared to the contralateral control leg, and 50% of the
EDL mass, respectively (Figures 1B,C). Despite this significant
decrease in muscle mass we found a 1.6-fold increase in MPS
in the TA (Figure 4). To our knowledge, this is the first study
finding such a pronounced increase in integrated MPS despite
absolute atrophy of the muscle. This supports the notion that
MPS rates may be more indicative of muscle remodeling and
ongoing regeneration than muscle growth per se (Ochala et al.,
2011; Mitchell et al., 2014; Damas et al., 2016).
The timing to assess muscle protein turnover is crucial to the
understanding of the changes in muscle mass. It is well known
that the time course of muscle protein turnover in response to
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FIGURE 2 | (A) Histochemical analysis via Gomori trichrome staining reveals regenerating fibers, centrally located nuclei and necrosis (upper panel). Toluidine blue
staining shows fiber type specificity (lower panel). (B) Quantification of Feret’s diameter reveals pronounced type 2b fiber atrophy (n = 5). (C) No significant difference
in number of muscle fibers between damaged and control muscle (n = 3). (D) Decreased lean body mass, increased fat mass and increased body water content
28 days post surgery (n = 8). ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
an atrophic stimulus is dynamic and depends on a variety of
parameters. For example in muscle disuse atrophy, the majority
of the changes to muscle protein turnover occur within the
first week after the onset of the stimulus (Wall et al., 2016). It
is thought that MPS decreases rapidly being accompanied by
swift muscle loss, both tapering off in the second and third
week of disuse (Wall et al., 2013a,b). Therefore, assessing muscle
protein synthesis at a later time point may miss important
changes. In respect to nerve damage, the literature suggests a
fairly steady rate of muscle loss (Goldspink, 1976; al-Amood
et al., 1991; Ma et al., 2007). It is important to note that
the muscle continues to lose mass up to 3–12 months after
nerve damage (Wu et al., 2014). To avoid any artifacts due
to an initial inflammatory response induced by the surgery,
we chose to analyze MPS during the second half of our
intervention. We used D2O as a tracer to measure integrated
protein synthesis over the course of 2 weeks (Figure 3C). As
opposed to a short term experiment with the constant infusion-
or flooding method, this allowed us to assess chronic alterations
of MPS.
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FIGURE 3 | (A) Schematic principle of D2O labeling protocol in rats (left) and muscle (right). (B) Quantification of the incorporation of 2H into m+1 of the myofibrillar
alanine fraction in unlabeled background muscle (n = 4) versus D2O labeled muscle (n = 40). (C) Schematic representation of the study protocol. Surgery at day 0,
start of the labeling experiment with D2O labeling on day 14 and assessment of myofibrillar protein synthesis between day 14 and day 28. ∗∗∗p < 0.001.
FIGURE 4 | Myofibrillar fractional protein synthesis rates in nerve damaged TA
and contralateral control (n = 10). ∗∗∗p < 0.001.
To investigate changes in protein expression that may
be underlying the observed changes in protein turnover, we
analyzed key signaling proteins for muscle protein synthesis
and breakdown. For muscle protein synthesis we focused on
p70s6k1, a protein downstream of mTORC1, known to increase
protein synthesis upon phosphorylation and with a regulatory
role in muscle growth (Baar and Esser, 1999; Saxton and
Sabatini, 2017). To gain insight into the signaling underlying
protein breakdown, we analyzed the E3 ubiquitine ligases MAFbx
and MuRF1. These are muscle specific proteins downstream
of FOXO, which have been shown to be upregulated under
most atrophic conditions and are crucial regulators of muscle
loss (Bodine et al., 2001; Gomes et al., 2001; Bodine and
Baehr, 2014). In our model, protein expression of p70s6k1 is
significantly increased in the nerve damaged leg compared to the
control leg (Figure 5A, lower panel). The expression of p70s6k1
correlates with fractional synthesis rates of myofibrillar protein
(Figure 6A). Interestingly that is still the case when expression
and synthesis rates are analyzed exclusively in the control leg
(Supplementary Figure 8). We tried to analyze phosphorylated
p70s6k1, but failed to detect any in both, the damaged and
the control legs. We confirmed the absence of phosphorylated
p70s6k1 in our samples by the addition of positive controls
(Supplementary Figure 6). The lack of phosphorylated p70s6k1
is not surprising, as the expression pattern appears to be transient
and sampling of muscle would have to occur closely to the
initiation of an early stimulus, which was not the case in our
study (Ogasawara et al., 2013; West et al., 2016). Eventually, in
case of our atrophy model the protein expression data seems
to line up with the protein turnover data from the tracer
experiments.
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FIGURE 5 | (A) Protein expression of MAFbx and p70s6k1 in contralateral (ctrl) and damaged (Dmg) rat TA; representative pictures of blots (n = 6). ∗∗p < 0.01,
∗∗∗p < 0.001.
FIGURE 6 | (A) Correlation between p70s6k1 protein expression and
myofibrillar fractional synthesis rates (FSR) in rat TA (n = 6).
CONCLUSION
In summary, we found that nerve damage induced muscle loss is
primarily based on muscle fiber atrophy, not the loss of muscle
fibers. With the combination of integrating the D2O tracer
method with the analysis of absolute changes in muscle mass, we
were able to find that in our model of muscle atrophy, muscle
loss is accompanied by an increase as opposed to a decrease
in MPS rates. These findings support the notion that muscle
protein synthesis may be reflective of muscle remodeling and
should not be used as a proxy to predict changes in muscle mass.
In conclusion, muscle atrophy caused by chronic constriction
injury to the nerve is not associated with a decline in MPS
rates.
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